INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
University of Western Australia
Perth, AustraliaPublicacións en colaboración con investigadores/as de University of Western Australia (2)
2024
-
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial
The Lancet, Vol. 403, Núm. 10444, pp. 2597-2605
2020
-
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics, Vol. 52, Núm. 1, pp. 56-73